1. Home
  2. AUNA vs RAPP Comparison

AUNA vs RAPP Comparison

Compare AUNA & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUNA
  • RAPP
  • Stock Information
  • Founded
  • AUNA 1989
  • RAPP 2022
  • Country
  • AUNA Luxembourg
  • RAPP United States
  • Employees
  • AUNA N/A
  • RAPP N/A
  • Industry
  • AUNA
  • RAPP
  • Sector
  • AUNA
  • RAPP
  • Exchange
  • AUNA NYSE
  • RAPP Nasdaq
  • Market Cap
  • AUNA 484.0M
  • RAPP 450.0M
  • IPO Year
  • AUNA 2024
  • RAPP 2024
  • Fundamental
  • Price
  • AUNA $6.30
  • RAPP $11.80
  • Analyst Decision
  • AUNA Buy
  • RAPP Strong Buy
  • Analyst Count
  • AUNA 1
  • RAPP 5
  • Target Price
  • AUNA $13.50
  • RAPP $35.00
  • AVG Volume (30 Days)
  • AUNA 63.2K
  • RAPP 189.2K
  • Earning Date
  • AUNA 08-20-2025
  • RAPP 08-07-2025
  • Dividend Yield
  • AUNA N/A
  • RAPP N/A
  • EPS Growth
  • AUNA N/A
  • RAPP N/A
  • EPS
  • AUNA 0.58
  • RAPP N/A
  • Revenue
  • AUNA $1,187,208,994.00
  • RAPP N/A
  • Revenue This Year
  • AUNA $6.45
  • RAPP N/A
  • Revenue Next Year
  • AUNA $7.62
  • RAPP N/A
  • P/E Ratio
  • AUNA $10.80
  • RAPP N/A
  • Revenue Growth
  • AUNA 7.24
  • RAPP N/A
  • 52 Week Low
  • AUNA $6.11
  • RAPP $6.43
  • 52 Week High
  • AUNA $9.38
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • AUNA N/A
  • RAPP N/A
  • Support Level
  • AUNA N/A
  • RAPP N/A
  • Resistance Level
  • AUNA N/A
  • RAPP N/A
  • Average True Range (ATR)
  • AUNA 0.00
  • RAPP 0.00
  • MACD
  • AUNA 0.00
  • RAPP 0.00
  • Stochastic Oscillator
  • AUNA 0.00
  • RAPP 0.00

About AUNA AUNA S A

Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: